1.
J Indian Med Assoc
; 104(1): 42, 44, 2006 Jan.
Article
in English
| MEDLINE
| ID: mdl-16850866
ABSTRACT
Recombinant factor VIIa is a novel haemostatic agent and was originally developed to treat haemophilia patients. Successful use of the factor in a 30-year-old male patient with pelvic fracture haemorrhage is being described by the authors.